HEPC-based liposomes trigger cytokine release from peripheral blood cells: effects of liposomal size, dose and lipid composition

被引:8
作者
Yamamoto, S
Ishida, T
Inoue, A
Mikami, J
Muraguchi, M
Ohmoto, Y
Kiwada, H [1 ]
机构
[1] Univ Tokushima, Grad Sch Pharmaceut Sci, Fac Pharmaceut Sci, Dept Pharmacokinet & Biopharmaceut, Tokushima 7708505, Japan
[2] Otsuka Pharmaceut Co Ltd, Tokushima 7710192, Japan
关键词
liposome; cytokine; human peripheral blood cell; whole-blood induction; immune system;
D O I
10.1016/S0378-5173(02)00026-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The immune response caused by liposome stimulation was studied by assessing the level of several cytokines released from human peripheral blood cells. Liposome stimulation resulted in the release of IL-6, IL-10, TNF-alpha and IFN-gamma. The size of the liposomes affected the degree of the cytokine releases with larger sized liposomes causing higher levels of cytokine induction. In addition. it appears that the lipid composition of liposomes had no effect on the degree of cytokine release. The release of cytokines occurred even in the absence of serum, suggesting that serum proteins did not contribute to liposome stimulation in peripheral blood cells. The release of cytokines induced by liposome stimulation was inhibited by the presence of either protein kinase-C (PKC) or protein tyrosine kinase (PTK) inhibitor, but not by the presence of an endocytosis inhibitor. This indicates that signal transduction via PKC or PTK is necessary, in order for human peripheral blood cells to release cytokines (IL-6, IL-10, IL-1beta, TNF-alpha and IFN-gamma) as the result of liposome stimulation. These quantitative data on the release of cytokines by liposomal stimulation provide useful information for the development of rational drug delivery systems and the safety of cytokine induction via the use of liposomes. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:125 / 133
页数:9
相关论文
共 25 条
[11]   SYNTHESIS, CHARACTERIZATION, AND SOME IMMUNOLOGICAL PROPERTIES OF CONJUGATES COMPOSED OF THE DETOXIFIED LIPOPOLYSACCHARIDE OF VIBRIO-CHOLERAE O1 SEROTYPE INABA BOUND TO CHOLERA-TOXIN [J].
GUPTA, RK ;
SZU, SC ;
FINKELSTEIN, RA ;
ROBBINS, JB .
INFECTION AND IMMUNITY, 1992, 60 (08) :3201-3208
[12]   ADJUVANTS - A BALANCE BETWEEN TOXICITY AND ADJUVANTICITY [J].
GUPTA, RK ;
RELYVELD, EH ;
LINDBLAD, EB ;
BIZZINI, B ;
BENEFRAIM, S ;
GUPTA, CK .
VACCINE, 1993, 11 (03) :293-306
[13]   MOLECULAR ADJUVANTS AND IMMUNOMODULATORS - NEW APPROACHES TO IMMUNIZATION [J].
JOHNSON, AG .
CLINICAL MICROBIOLOGY REVIEWS, 1994, 7 (03) :277-289
[14]   Lipopolysaccharide-stimulated TNF-α release from cultured rat Kupffer cells:: sequence of intracellular signaling pathways [J].
Lichtman, SN ;
Wang, J ;
Lemasters, JJ .
JOURNAL OF LEUKOCYTE BIOLOGY, 1998, 64 (03) :368-372
[15]  
Lyass O, 2000, CANCER, V89, P1037, DOI 10.1002/1097-0142(20000901)89:5<1037::AID-CNCR13>3.0.CO
[16]  
2-Z
[17]   Clinical efficacy and prospects for use of pegylated liposomal doxorubicin in the treatment of ovarian and breast cancers [J].
Muggia, FM .
DRUGS, 1997, 54 (Suppl 4) :22-29
[18]  
Naidu Mamta D., 1999, Indian Journal of Experimental Biology, V37, P283
[19]   LIPOSOMAL AMPHOTERICIN-B (AMBISOME) IN THE TREATMENT OF COMPLICATED KALA-AZAR UNDER FIELD CONDITIONS [J].
SEAMAN, J ;
BOER, C ;
WILKINSON, R ;
DEJONG, J ;
DEWILDE, E ;
SONDORP, E ;
DAVIDSON, R .
CLINICAL INFECTIOUS DISEASES, 1995, 21 (01) :188-193
[20]   LPS-induced NF-κB activation and TNF-α release in human monocytes are protein tyrosine kinase dependent and protein kinase C independent [J].
Shames, BD ;
Selzman, CH ;
Pulido, EJ ;
Meng, XZ ;
Meldrum, DR ;
McIntyre, RC ;
Harken, AH ;
Banerjee, A .
JOURNAL OF SURGICAL RESEARCH, 1999, 83 (01) :69-74